The report highlights the company's commitment to global social responsibility, focusing on vaccine equity, democratizing access to novel medicine, and technological innovation in healthcare. The report outlines specific initiatives such as the BioNTainer program for mRNA vaccine production in Africa, and the company's dedication to sustainable development with a 1.5°C climate protection pathway. Notably, the report emphasizes BioNTech's commitment to ethical and responsible business practices, as highlighted by its prime ESG rating and the implementation of a robust compliance program.
Issuing Company BioNTech SE
Report Type Sustainability Report
Report Language EN
Report Filesize 4.56 MB
No. of Pages 96 pages
Reporting periodJanuary 1, 2020-December 31, 2021
Report EditionUnknown
Assurance Provider Unknown
Reporting Standards GRI; SASB; UNGC; others
Materiality Assessmenttrue
